thalidomide has been researched along with Focal Neurologic Deficits in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FRENKEL, H | 1 |
| COHEN, S | 1 |
| Sheskin, J | 1 |
1 trial available for thalidomide and Focal Neurologic Deficits
| Article | Year |
|---|---|
[Therapeutic experience on the effect of thalidomidomide on lepra reaction].
Topics: Aspirin; Climate; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Israel; Lepro | 1975 |
2 other studies available for thalidomide and Focal Neurologic Deficits
| Article | Year |
|---|---|
[Contergan--side effects. Central nervous system manifestations and polyneuritic symptoms in long-term medication with N-phthalyl glutamic acid imide].
Topics: Glutamic Acid; Humans; Hypnotics and Sedatives; Imides; Nervous System Physiological Phenomena; Neur | 1961 |
Thalidomide polyneuropathy.
Topics: Humans; Neurologic Manifestations; Polyneuropathies; Thalidomide | 1962 |